Références des articles scientifiques publiés en 2023

Chaque année, l’Assurance Maladie produit de nombreuses études (rapports, articles scientifiques, communications en congrès ou en colloques, etc.), seule ou en partenariat avec des équipes institutionnelles ou de recherche.

La plupart de ces études s'appuient sur des données issues du système national des données de santé (SNDS). Pour en savoir plus, consulter l'article Présentation du SNDS.

Certaines de ces études ont fait l'objet d'une publication dans des revues à comité de lecture telles que : The Lancet, The British Medical Journal (BMJ), Pharmacoepidemiology and Drug Safety (PDS), le Bulletin épidémiologique hebdomadaire (BEH), la Revue d'épidémiologie et de santé publique, etc.

La liste annuelle des différentes études publiés par l'Assurance Maladie est proposée ci-dessous, par ordre alphabétique.

La liste complète de ces articles est également proposée en téléchargement ci-dessous (au format PDF).

Articles publiés dans des revues à comité de lecture

*Artignan J, Capmas P, Panjo H, Constantinou P et Pelletier‑Fleury N. Are breast cancer patients with suboptimal adherence to cardiovascular treatment more likely to discontinue adjuvant endocrine therapy? Competing risk survival analysis in a nationwide cohort of postmenopausal women. BMC Med. 21, 463. 2023, Nov.

Billioti de Gage S, Jourdain H, Desplas D, Dray-Spira R. Roll-out and effectiveness of HIV pre-exposure prophylaxis in France: An overview. Therapie. 2023 Feb.

*Champeaux-Depond C, Jecko V, Weller J, Constantinou P, Tuppin P, Metellus P. Newly Diagnosed High-Grade Glioma Surgery with Carmustine Wafers Implantation. A Long-Term Nationwide Retrospective Study. World Neurosurg. 2023 May.

*Champeaux-Depond C, Jecko V, Weller J, Constantinou P, Tuppin P, Metellus P. Recurrent high grade glioma surgery with carmustine wafers implantation: a long-term nationwide retrospective study. J Neurooncol. 2023 Apr.

*Dugerdil A, Semenzato L, Weill A, Zureik M, Flahault A. Severe SARS-CoV-2 infection as a marker of undiagnosed cancer: a population-based study. Sci Rep. 2023 May.

*Florea SM, Passeri T, Abbritti R, Bernat AL, Fontanel S, Yoldjian I, Funck-Brentano T, Weill A, Mandonnet E, Froelich S. Opposed evolution of the osseous and soft parts of progestin-associated osteomeningioma after progestin intake discontinuation. J Neurosurg. 2023 Mar.

Fosse-Edorh S, Lavalette C, Piffaretti C, Saboni L, Bessonneau P, Mandereau Bruno L, Bénézet L, Assogba F, Devos F, Thouillot F, Léon L, Kandel M, Race JM, Rachas A pour le groupe Entred – DROM. Caractéristiques, état de santé et recours aux soins des personnes présentant un diabète de type 2 résidant en outre-mer : résultats de l’étude Entred 3. Bull Épidémiol Hebd. 2023 Nov.

*Grave C, Gabet A, Cinaud A, Tuppin P, Blacher J, Olié V. Nationwide time trends in patients hospitalized for acute coronary syndrome: a worrying generational and social effect among women. Eur J Prev Cardiol. 2024 Jan.

*Haneef R, Fayad M, Fouillet A, Sommen C, Christophe Bonaldi, Grant M A Wyper, Monteiro Pires S, Devleesschauwer B, Rachas A, Constantinou P, Levy-Bruhl D, Beltzer N, Gallay A. Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020. PLoS One. 2023 Jan.

Hoisnard L, Pina Vegas L, Dray-Spira R, Weill A, Zureik M, Sbidian E. Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study. Ann Rheum Dis. 2023 Feb.

Jabagi MJ, Bertrand M, Botton J, Le Vu S, Weill A, Dray-Spira R, Zureik M. Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster. N Engl J Med. 2023 Apr.

Jourdain H, Hoisnard L, Sbidian E, Zureik M. Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System. BioDrugs. 2023 May.

Kolla E, Weill A, Zaidan M, De Martin E, Colin De Verdiere S, Semenzato L, Zureik M, Grimaldi L. COVID-19 Hospitalization in Solid Organ Transplant Recipients on Immunosuppressive Therapy. JAMA Netw Open. 2023 Nov.

Laanani M, Weill A, Jollant F, Zureik M, Dray-Spira R. Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study. Sci Rep. 2023 Mar.

*Laruelle E, Huré F, Dolley-Hitze T, Vanorio-Vega I, Bayat S, Couchoud C, REIN registry. Home Dialysis Does Not Have the Monopoly on Low Cost. Kidney Int Rep. 2022 Oct.

Le Vu S, Bertrand M, Botton J, Jabagi MJ, Drouin J, Semenzato L, Weill A, Dray-Spira R, Zureik M. Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines: A Nationwide Self-controlled Case Series Study. Neurology. 2023 Oct.

Marcombes C, Penso L, Weill A, Dray-Spira R, Zureik M, Sbidian E. Persistence of second-line biologics in psoriasis after first-line biologic failure: a nationwide cohort study from the French health insurance database (SNDS). Br J Dermatol. 2023 Jul.

Meyer A, Rios P, Drouin J, Weill A, Carbonnel F, Dray-Spira R. Maternal Exposure to Anti-TNF or Thiopurines for IBD Does Not Increase Risk of Early-life Malignancy in Children. Clin Gastroenterol Hepatol. 2023 Sep.

*Mroué A, Roueff S, Vanorio-Vega I, Lazareth H, Kovalska O, Flahault A, Tuppin A, Thervet E, MC Iliou. Benefits of Cardiac Rehabilitation in Cardio-Renal Patients With Heart Failure With Reduced Ejection Fraction. J Cardiopulm Rehabil Prev. 2023 Mar 10.

Nicolas M, Verboux D, Rachas A, Debeugny G. Quelles sont les différences de reste à charge selon le bénéfice de l’affection de longue durée pour les personnes avec un cancer colorectal incident en 2016 ? Journal de gestion et d'économie de la santé 2023/1 (N 1), pages 23 à 44. Mis en ligne sur Cairn.info le 03/08/2023.

*Obadia MA, Woimant F, Tuppin P, Debray D, Poujois A. Reply to "Epidemiology, treatment and burden of Wilson disease in France: A 10-year analysis of the National health insurance database". Clin Res Hepatol Gastroenterol 2023 Dec.

Ouazana-Vedrines C, Lesuffleur T, Denis P, Hoertel N, Limosin F, Rachas A, Tuppin P, Lemogne C. Using filled prescription sequences to rank antidepressants: A nationwide replication study. J Psychiatr Res. 2023 Feb.

Pergeline J, Lesuffleur T, Rey S, Fresson J , Rachas A, Tuppin P. Long-term chronic diseases and 1-year use of healthcare services by children under 18 years of age during 2018-2019: A French nationwide observational study. Observational Study. Arch Pediatr. 2023 Jan.

Pergeline J, Rey S, Fresson J, Debeugny G, Rachas A, Tuppin P. Factors associated with hospital admission and 30-day readmission for children less than 18 years of age in 2018 in France: a one-year nationwide observational study. BMC Health Serv Res. 2023 Aug.

Pergeline J, Rivière S, Rey S, Fresson J, Rachas A, Tuppin P. Social deprivation and the use of healthcare services over one year by children less than 18 years of age in 2018: A French nationwide observational study. PLoS One. 2023 May.

Pina Vegas L, Drouin J, Dray-Spira R, Weill A. Prevalence, mortality, and treatment of patients with rheumatoid arthritis: A cohort study of the French National Health Data System, 2010-2019. Joint Bone Spine. 2023 Jan.

Rachas A, Fontaine R, Thomas M, Robine JM, Gavazz G, Laurent M, Carcaillon-Bentata L, Canouï-Poitrine F. Individual and contextual risk factors for mortality in nursing home residents during the first wave of COVID-19 in France: a multilevel analysis of a nationwide cohort study. Age Ageing. 2023 Aug.

Roland N, Baricault B, Dray-Spira R, Weill A, Duranteau L, Zureik M. Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population-based study. Int J Gynaecol Obstet. 2023 Feb.

Roland N, Baricault B, Weill A, Bouillon K, Dray-Spira R, Duranteau L, Zureik M. Association Between Doses of Levonorgestrel Intrauterine Systems and Subsequent Use of Psychotropic Drugs in France. JAMA. 2023 Jan.

Roland N, Drouin J, Desplas D, Duranteau L, Cuenot F, Dray-Spira R, Weill A, Zureik M. Impact of coronavirus disease 2019 on contraception use in France. Therapie. 2023 Jan.

Sbidian E, Penso L, Herlemont P, Botton J, Baricault B, Semenzato L, Drouin J, Weill A, Dray-Spira R, Zureik M. Comment on 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France. Ann Rheum Dis. 2023 May.

Semenzato L, Botton J, Le Vu S, Jabagi MJ, Cuenot F, Drouin J, Dray-Spira R, Weill A, Zureik M. Protection of Covid-19 vaccination against hospitalisation during the era of Omicron BA.4 and BA.5 predominance: a nationwide case-control study based on the French National Health Data System. Open Forum Infectious Diseases, 2023.

*Torres MJ, Coste J, Canouï-Poitrine F, Pouchot J, Rachas A, Carcaillon-Bentata L. Impact of the first COVID-19 pandemic wave on hospitalizations and deaths caused by geriatric syndromes in France: a nationwide study. J Gerontol A Biol Sci Med Sci. 2023 Jan.

Tran A, Zureik M, Sibiude J, Drouin J, Miranda S, Weill A, Dray-Spira R, Duval X, Tubiana S. Prevalence and associated factors of antibiotic exposure during pregnancy in a large French population-based study during the 2010-19 period. J Antimicrob Chemother. 2023 Aug.

Tubiana S, Sibiude J, Herlemont P, Drouin J, Picone O, Duval X, Weill A, Zureik M, Dray-Spira R. Trends in anti-infective use during pregnancy in France between 2010 and 2019: a nationwide population-based study. Br J Clin Pharmacol. 2023 May.

Tuppin P, Barthelemy P, Debeugny G, Rachas A. A French nationwide study compared various conditions and healthcare use of individuals < 65 years with a Down's syndrome to those without. Sci Rep. 2023 Dec.

Tuppin P, Béchade C, Couchoud C. REIN: a tool at the service of health authorities. Nephrol Ther. 2023 Aug.

Vanorio-Vega I, Constantinou P, Bret V, Gentile S, Finne P, Sautenet B, Tuppin P, Couchou. Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy considering the treatment modality and duration in a French cohort. Eur J Health Econ. 2023 Apr 1.

Vanorio‑Vega I, Constantinou P, Hami A, Cellarier E, Rachas A, Tuppin P, Couchoud C. Cross-validation of comorbidity items in two national databases in a sample of patients with end-stage kidney disease. BMC Health Serv Res. 2023 Oct.

Zureik M, Cuenot F, Weill A, Dray-Spira R. Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines. Therapie. 2023 Jan.

Publications diverses

Mazza M (Cnam), Smadja L (Cnam), Peyre-Lanquar G (Cnam), Tuppin P (Cnam), Duburcq  A (Cemka, Bureau d’études d’évaluation médicale), Bahrami S (Université Paris-Saclay/Université de Versailles Saint-Quentin, Inserm CESP, Equipe PSYDEV), Schramm S (Cnam). Prise en charge des thérapies non médicamenteuses pour des troubles en santé mentale d’intensité légère à modérée - Enseignements sur l’expérimentation de remboursements de séances d’accompagnement psychologique proposées par le médecin généraliste et conduites par des psychologues cliniciens/psychothérapeutes en ville, de 2018 à 2022. Points de repère n° 53. Septembre 2023.

* Ces études ont été réalisées par des équipes extérieures à l’Assurance Maladie, avec l’appui et la participation de la Cnam.